Phenylbutazone Sodium 200 mg/mL
(equivalent to Phenylbutazone Base 186 mg/mL)
Sodium Salicylate 50 mg/mL
100mL single vial
For the rapid relief of painful musculoskeletal conditions in horses. Such conditions include arthritis, arthrosis, osteitis, osteoarthritis, bursitis, tendonitis, tenosynovitis and the inflammation of soft tissues (including laminitis) and skin..
Phenylbutazone is a non-steroidal anti-inflammatory and analgesic agent. Sodium salicylate is an antipyretic analgesic agent. The combination of these two drugs provides both rapid action (sodium salicylate) and prolonged effect (phenylbutazone).
When used for the relief of febrile conditions, treatment of the underlying cause should be provided concurrently with Platinum Bute IV Injection.
The safety of Platinum Bute IV has been evaluated at doses of up to 20 mL/225 kg (Day 1) and 10 mL/225 kg (Days 2-5), without any adverse effect.
This product is contraindicated for use in horses with serious cardiac, hepatic or renal dysfunction, history of blood disorders (especially haemoglobinuria) or gastro-intestinal disturbances.
Toxic reactions to Platinum Bute IV Injection are uncommon, but may be expressed as oedema of legs, jaundice, blood dyscrasia, gastric irritation or ulceration of the large intestine..
DOSAGE AND ADMINISTRATION
Administer by slow intravenous injection of solution at room temperature.
Horses and Foals
Initially 5-10 mL per 225 kg per day. Subsequent doses, depending on response, may be reduced to 2.5-5 mL per 225 kg per day. Treatment may be continued for 5-6 days if required.
MEAT WITHHOLDING PERIOD
NOT TO BE USED in horses intended for human consumption.
RACING/EVENT WITHHOLDING PERIOD
If used in performance animals, the regulations of the relevant authorities regarding medication should be observed.
If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126 or in New Zealand 0800 764 766.
Dispose of empty container by wrapping with paper and putting in garbage. Discarded needles/sharps should immediately be placed in a designated and appropriately labelled “sharps” container..
Store between 2 and 8°C (Refrigerate. Do not freeze). Protect from light. Store vials in an upright position.
Following withdrawal of the first dose, use the remainder of the vial within 4 days or discard the unused portion.
APVMA Approval No. 68303/58052 (Australia)